Previous work in vitiligo, an autoimmune disease characterized by CD8+ T cells targeting melanocytes, demonstrated an essential role for CXCL9 and CXCL10 in the recruitment of CD8+ T cells to skin (10, 11). This evidence concerns the gene CXCL10 and vitiligo.